B4GALNT1 is also upregulated in hepatocellular carcinoma (HCC) and plays a role in immunosuppression, with the silencing of B4GALNT1 improving tumour-killing in mouse models treated with programmed cell death protein 1 targeting strategies16. Here, B4GALNT1 is linked to neoplasm.